Clinical Trials Browser

Phase 3 × Ganglioneuroblastoma × High-Energy Shock Waves × Clear all

NCT02176967 2025-12-22

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Phase 3 Active not recruiting

Neuroblastoma, Ganglioneuroblastoma